Abstract Interindividual variability in clinical response to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) represents a significant challenge in the management of obesity and type 2 diabetes (T2D)
Contrary to popular opinion, taurine is actually not a stimulant
It is an anti-ulcer peptide (9-12), interacting with NO-system (13), and, unlike other peptides, it is particularly stable in gastric juice (14) and is used consistently without a carrier (9-11, 13-24), being safe in patients with the inflammatory bowel disease (coded PL-10, PLD 116, PL 14736) (21)
This IV contains higher concentrations of Vitamin C, Glutathione, Zinc, Carinitine and Arginine